Can you provide the last earnings date for BIOMEA FUSION INC?
BIOMEA FUSION INC (BMEA) last reported earnings on 11/4/2025.
NASDAQ:BMEA • US09077A1060
Past quarterly earnings results for BIOMEA FUSION INC (BMEA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.27 | -0.26 | -3.47% | 70.33% | - | - | ||
| Q2 2025 | -0.51 | -0.54 | 5.77% | 50.49% | - | - | ||
| Q1 2025 | -0.80 | -0.62 | -28.20% | 26.61% | - | - | ||
| Q4 2024 | -0.81 | -0.94 | 13.79% | 17.35% | - | - | ||
| Q3 2024 | -0.91 | -0.97 | 6.07% | -13.75% | - | - | ||
| Q2 2024 | -1.03 | -1.09 | 5.70% | -47.14% | - | - | ||
| Q1 2024 | -1.09 | -1.01 | -7.49% | -11.22% | - | - | ||
| Q4 2023 | -0.98 | -0.87 | -12.83% | -13.95% | - | - | ||
| Q3 2023 | -0.80 | -0.84 | 4.72% | -2.56% | - | - | ||
| Q2 2023 | -0.70 | -0.89 | 21.58% | -18.64% | - | - | ||
| Q1 2023 | -0.98 | -0.83 | -18.53% | -75.00% | - | - | ||
| Q4 2022 | -0.86 | -0.83 | -3.60% | -68.63% | - | - | ||
| Q3 2022 | -0.78 | -0.66 | -17.65% | -81.40% | - | - | ||
| Q2 2022 | -0.59 | -0.61 | 3.92% | -78.79% | - | - | ||
| Q1 2022 | -0.56 | -0.54 | -4.38% | -14.29% | - | - | ||
| Q4 2021 | -0.51 | -0.45 | -12.11% | - | - | - | ||
| Q3 2021 | -0.43 | -0.40 | -6.73% | - | - | - | ||
| Q2 2021 | -0.33 | -0.20 | -61.76% | - | - | - | ||
| Q1 2021 | -0.49 | -0.14 | -243.14% | - | - | - | ||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
BIOMEA FUSION INC (BMEA) last reported earnings on 11/4/2025.
BIOMEA FUSION INC (BMEA) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, BIOMEA FUSION INC (BMEA) has beaten EPS estimates in 2 out of 4 releases.